Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a behind-the-scenes release rather than changes to the clinical trial details presented.
    Difference
    0.1%
    Check dated 2026-04-24T06:27:43.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:53.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Results status updated from 'No Results Posted' to 'Results Submitted'. This indicates that trial results have been submitted for posting.
    Difference
    0.1%
    Check dated 2026-04-02T15:42:01.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:20:45.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:15:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Updated sponsor/collaborator naming to Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. Removed the former names Sidney Kimmel Cancer Center at Thomas Jefferson University and the parenthetical Thomas Jefferson University (Sidney Kimmel Cancer Center at Thomas Jefferson University).
    Difference
    0.3%
    Check dated 2026-02-25T19:43:33.000Z thumbnail image

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.